H‐2Kb TRANSFECTION OF B16 MELANOMA CELLS RESULTS IN REDUCED TUMOURIGENICITY AND METASTATIC COMPETENCE

A. Porgador, M. Feldman, L. Eisenbach

Research output: Contribution to journalArticlepeer-review

60 Scopus citations

Abstract

The metastatic B16 mouse melanoma shows a low cell surface expression of H‐2Kb and H‐2Db class I antigens on cells of both the high‐metastatic line B16‐F10 and the low‐metastatic line B16‐F1. Similarly, newly generated clones of these lines, having different metastatic properties, all express low levels of major histo‐compatibility antigens. One of these clones, the high‐metastatic F10.9, was transfected with H‐2Kb genes to generate H‐2Kb‐expressing transfectants. The resulting clones showed reduced tumourigenicity and a low metastatic phenotype. Unlike the parental cells, H‐2Kb‐positive transfectants are potent inducers and sensitive targets of H‐2Kb‐restricted syngeneic cytotoxic T cells. Immunization of mice with H‐2Kb‐positive transfectants conferred protection against a subsequent challenge with Kb‐positive transfectants but had only a small effect on growth and metastatic spread of parental cells.

Original languageEnglish
Pages (from-to)291-303
Number of pages13
JournalInternational Journal of Immunogenetics
Volume16
Issue number4-5
DOIs
StatePublished - 1 Jan 1989
Externally publishedYes

Fingerprint

Dive into the research topics of 'H‐2Kb TRANSFECTION OF B16 MELANOMA CELLS RESULTS IN REDUCED TUMOURIGENICITY AND METASTATIC COMPETENCE'. Together they form a unique fingerprint.

Cite this